EpiTan Ltd. - Clinuvel Pharmaceuticals

Currency Exchange Rates:
1 AUD = 0.7267 USD = 0.5915 EUR
Source:
EpiTan Limited
MIDAS Research GmbH
www.reuters.com
www.maxblue.de
www.marketresearch.com
www.yahoo.com.au
www.bigcharts.com
www.emedicine.com
MIDAS Research Subscription
If you like to receive our research directly by Email please register on our Web Site
http://www.midasresearch.de under „RESEARCH ABO“
Disclaimer
This report is not suited for any individuals resident in any jurisdiction in which access to such reports is regulated by
applicable laws. No investment decision must be based on any aspect of, or statement in, this report. If you are
uncertain if this might apply in your case you should not access and consider this report.
This publication was produced by MIDAS Research GmbH. It represents only a non-binding view of the development of the capital markets as
well as of quoted companies and gives information about the composition and/or change of the model portfolio as composed by MIDAS Research
GmbH. Purpose of the publication is to supply information for the shaping of a personal opinion. The publication does not constitute any
investment advice or recommendation of certain stock exchange transactions and cannot replace professional investment advice. Each reader
remains requested to consult his personal investment advisor to discuss a possible purchase or sale of any of the securities mentioned in the
publication before carrying out any such investment transaction. Data and facts forming basis of this publication have not been separately
verified by MIDAS Research GmbH and MIDAS Research GmbH does not assume any liability for the content of this publication. If this
publication contains opinions as far as the future development of prices of securities or of the business development of enterprises is concerned
these are mere forecasts. The probability that forecast circumstances materialize is subject to substantial risk and can be assured in no way. Any
views expressed in the publication or information about the model portfolio composed by MIDAS Research are only valid for the point in time as
stated on the report and may change at any time without further notice.
MIDAS Research GmbH does not conduct own account trading in shares or related derivatives of the companies discussed in this publication. This
applies also to the authors and other persons connected with MIDAS Research GmbH, if they are familiar with the content of the publication or
could have been familiar due to their business relation with MIDAS Research GmbH, however MIDAS Research GmbH does not assume any
liability to the aforementioned.
If MIDAS Research GmbH directly or indirectly maintains or has directly or indirectly maintained within the last five calendar years Paid
Research Agreements or other Service Agreements with companies mentioned in this report these companies are indicated in the following:
EpiTan Ltd.
Any reproduction, change or use of this publication without previous written agreement of MIDAS Research GmbH is inadmissible.
EMAIL: info@midas-research.de INTERNET: http://www.midasresearch.de CONTACT: Simone Drepper (responsible) +49 621/430 613 0